adrenal gland hyperfunction
adrenal gland hyperfunction
Explore linked clinical trials. Standard reference: MONDO:0006640107 results · Page 1 of 5
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, carcinoma, cardiovascular disorder, central nervous system disorder, diabetes mellitus, ectopic ACTH secretion syndrome, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hyperpituitarism, hypertensive disorder, hypothalamic disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder, type 2 diabetes mellitus, vascular disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT03604198 | |
| Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks | Bone Diseases, Metabolic, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, bone disorder, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperaldosteronism, hyperinsulinism, hypertensive disorder, malignant endocrine neoplasm, metabolic disease, musculoskeletal system disorder, neoplasm, paraneoplastic syndrome, vascular disorder | Recruiting | Not stated | 2026-10-08 | NCT03374215 | |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Cushing syndrome, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, diabetes mellitus, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, metabolic disease, neoplasm, paraneoplastic syndrome, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-10-06 | NCT07296484 | |
| Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities | Apnea, Arrhythmias, Cardiac, Dyssomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sleep Disorders, Intrinsic, adrenal gland disorder, adrenal gland hyperfunction, atrial fibrillation, cardiovascular disorder, endocrine system disorder, heart disorder, hyperaldosteronism, nervous system disorder, primary aldosteronism, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2026-10-05 | NCT07857044 | |
| Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism | Recruiting | Not applicable | 2026-10-02 | NCT07297745 | |
| Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder | Recruiting | Phase 2 | 2026-10-02 | NCT02019706 | |
| Evaluation of Adults With Endocrine and Metabolic-Related Conditions | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder | Recruiting | Not stated | 2026-09-28 | NCT02830308 | |
| Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Recruiting | Phase 2 | 2026-09-25 | NCT07138274 | |
| Metyrapone for Mild Autonomous Cortisol Secretion (MACS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Active, not recruiting | Phase 2 | 2026-09-25 | NCT06106295 | |
| Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism | Cushing syndrome, Neoplasms by Histologic Type, adenoma, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, epithelial neoplasm, hyperaldosteronism, neoplasm | Recruiting | Phase 2 | 2026-09-23 | NCT06246357 | |
| Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not applicable | 2026-09-21 | NCT07673445 | |
| Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS) | ACTH-dependent Cushing syndrome, Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Recruiting | Not stated | 2026-09-18 | NCT04543253 | |
| SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-15 | NCT07687160 | |
| [11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Not applicable | 2026-09-11 | NCT07814105 | |
| A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, adrenocortical insufficiency, endocrine system disorder, endogenous Cushing syndrome | Recruiting | Not stated | 2026-09-09 | NCT06430528 | |
| Diagnosing Variable Primary Aldosteronism. | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, primary aldosteronism, vascular disorder | Recruiting | Not stated | 2026-09-08 | NCT05765786 | |
| Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Not applicable | 2026-09-02 | NCT07800858 | |
| Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, primary aldosteronism, vascular disorder | Not yet recruiting | Not applicable | 2026-08-31 | NCT07796048 | |
| A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 2 | 2026-08-31 | NCT07470983 | |
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome | Cushing syndrome, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, disease, endocrine system disorder | Recruiting | Phase 2 | 2026-08-31 | NCT06635629 | |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | Abnormalities, Multiple, Arrhythmias, Cardiac, COVID-19, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Down syndrome, Dyssomnias, Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Hemorrhage, Infant, Newborn, Diseases, Infant, Premature, Diseases, Infections, Inflammation, Kawasaki disease, Lung Injury, Menorrhagia, Menstruation Disturbances, Neurobehavioral Manifestations, Neurologic Manifestations, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, Suppuration, Urogenital Diseases, Uterine Hemorrhage, Ventilator-Induced Lung Injury, Water-Electrolyte Imbalance, adrenal gland disorder, adrenal gland hyperfunction, adrenocortical insufficiency, attention deficit hyperactivity disorder, inattentive type, blood coagulation disease, bronchopulmonary dysplasia, cardiovascular disorder, cellulitis, chromosomal disorder, coagulation protein disease, connective tissue disorder, endocrine system disorder, female reproductive system disorder, heart disorder, heart failure, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, hyperaldosteronism, hyperphosphatemia, hypertensive disorder, inherited blood coagulation disorder, insomnia, intellectual disability, lung disorder, lymphatic system disorder, metabolic disease, nervous system disorder, neurodevelopmental disorder, oppositional defiant disorder, pediatric multisystem inflammatory disease, COVID-19 related, phosphorus metabolism disease, pneumonia, potassium deficiency disease, primary aldosteronism, psychiatric disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection, skin infection, skin vascular disease, sleep-wake disorder, uterine disorder, vascular disorder, vascular hemostatic disease, vasculitis, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-21 | NCT04278404 | |
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperpituitarism, hypothalamic disorder, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT05804669 | |
| Prospective Phenotyping of Autonomous Aldosterone Secretion | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism | Active, not recruiting | Not stated | 2026-08-13 | NCT03484130 | |
| EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders | Body Weight, Cushing syndrome, Nutritional and Metabolic Diseases, Overweight, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperaldosteronism, hypertensive disorder, neoplasm, nutritional disorder, obesity disorder, overnutrition, paraneoplastic syndrome, primary aldosteronism, vascular disorder | Active, not recruiting | Not applicable | 2026-07-27 | NCT07727356 | |
| Salivary Cortisol and Hypercortisolism in Type 2 Diabetes | Cushing syndrome, Nutritional and Metabolic Diseases, adrenal gland disorder, adrenal gland hyperfunction, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not stated | 2026-07-27 | NCT07156370 |